- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572896
An Internet-based Self-management Program for Adolescents With Arthritis
March 31, 2017 updated by: Jennifer Stinson, The Hospital for Sick Children
An Internet-based Self-management Program for Adolescents With Arthritis: A Randomized Controlled Trial
The purpose of this study is to demonstrate the effectiveness of the "Taking Charge: Managing JIA Online" Internet intervention, when compared with an attention (static education only websites) control group in improving pain and HRQL as well as other health outcomes (anxiety, depression, treatment adherence, pain coping, knowledge, and self-efficacy) in adolescents with JIA.
The proposed study will enroll and randomize 294 adolescents with JIA attending 10 pediatric rheumatology hospital clinics in the Canada to either the experimental or control groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In summary, no rigorous Internet self-management intervention has been undertaken to improve HRQL, symptoms, treatment adherence, knowledge, and self-efficacy in youth with JIA.
The proposed "Managing JIA Online" Trial will rigorously examine the effects of this Internet intervention on HRQL and other health outcomes thereby filling a significant gap in our knowledge related to promotion of self-management care for adolescents with JIA.
Study Type
Interventional
Enrollment (Actual)
333
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Calgary, Canada
- Alberta Children's Hospital
-
Edmonton, Canada
- Stollery Children's Hospital
-
Halifax, Canada
- IWK Health Centre
-
Montreal, Canada
- Montreal Children's Hospital
-
Ottawa, Canada
- Children's Hospital of Eastern Ontario
-
Saskatoon, Canada
- Royal University
-
St. Johns, Canada
- Janeway Children's Health and Rehabilitation Centre
-
Vancouver, Canada
- BC Children's Hospital
-
Winnepeg, Canada
- Winnepeg Children's Hospital
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4K1
- Hamilton Health Sciences
-
Toronto, Ontario, Canada, M5V1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥12 and ≤ 18 years.
- Diagnosed with JIA (using International League of Associations for Rheumatology classification criteria)83 by their rheumatologist.
- Adolescents and parent/ primary caregiver are able to speak and read either English or French.
- Participants are willing and able to complete online measures. There will be no restrictions on medication use for this study.
Exclusion Criteria:
- Cognitive impairments (as assessed by reviewing medical chart and consultation with the patient's rheumatologist)
Major co-morbid illnesses which may mitigate HRQL assessment
- Excluded medical illnesses: inflammatory bowel disease, fibromyalgia, cancer, genetic disorders, diabetes
- Excluded psychiatric conditions: post-traumatic stress disorder, panic disorder, bipolar disorder, psychosis, depression and major mood disorders. Adolescents currently on medications for major depression, bipolar disorder or psychosis would also be excluded.
- Adolescents that are currently participating in other CBT interventions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
|
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention and through the 9-month follow-up period.
In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about JIA ("JIA Resource Centre") and online assessments.
|
|
Experimental: Taking Charge Experimental Group
|
In addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing JIA Online" Internet self-management program.
The intervention is a 12-module interactive multi-component treatment protocol - that consists of JIA-specific education, self-management strategies, and social support - that is available in English and French.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: 12 months
|
Pain will be measured using the Recalled Pain Inventory - Short Form.91
The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations.
This 11-item measure has evidence of construct validity
|
12 months
|
|
Health-related Quality of Life (HRQL)
Time Frame: Baseline
|
HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13
Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
|
Baseline
|
|
Pain
Time Frame: Baseline
|
Pain will be measured using the Recalled Pain Inventory - Short Form.91
The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations.
This 11-item measure has evidence of construct validity
|
Baseline
|
|
Pain
Time Frame: 3months
|
Pain will be measured using the Recalled Pain Inventory - Short Form.91
The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations.
This 11-item measure has evidence of construct validity
|
3months
|
|
Health-related Quality of Life (HRQL)
Time Frame: 6 months
|
HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13
Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
|
6 months
|
|
Pain
Time Frame: 6 months
|
Pain will be measured using the Recalled Pain Inventory - Short Form.91
The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations.
This 11-item measure has evidence of construct validity
|
6 months
|
|
Health-related Quality of Life (HRQL)
Time Frame: 3 months
|
HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13
Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
|
3 months
|
|
Health-related Quality of Life (HRQL)
Time Frame: 12 months
|
HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13
Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotional Symptoms
Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention
|
Anxiety and depression will each be assessed using two, separate 8-item PROMIS (Patient Reported Outcomes Measurement Information System) scales.
|
Baseline, 3 months, 6 months and 12 months post-intervention
|
|
Adherence
Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention
|
Adherence to medical treatment will be assessed using the 34-item Child Adherence Report Questionnaire (CARQ)
|
Baseline, 3 months, 6 months and 12 months post-intervention
|
|
Pain Coping
Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention
|
Pain coping will be measured using the 18-item Pain Coping Questionnaire106, which is an internationally used measure of pain coping strategies in the pediatric population and has been validated in youth with arthritis.
|
Baseline, 3 months, 6 months and 12 months post-intervention
|
|
Juvenile Idiopathic Arthritis (JIA)
Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention
|
JIA-specific knowledge will be measured using 9-items from the Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS).
|
Baseline, 3 months, 6 months and 12 months post-intervention
|
|
Self-Efficacy
Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention
|
Self-efficacy will be measured using the Children's Arthritis Self-Efficacy (CASE) scale which is an 11-item measure.
|
Baseline, 3 months, 6 months and 12 months post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer N Stinson, RN, PhD, CPNP, The Hospital for Sick Children
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
April 3, 2012
First Submitted That Met QC Criteria
April 4, 2012
First Posted (Estimate)
April 6, 2012
Study Record Updates
Last Update Posted (Actual)
April 4, 2017
Last Update Submitted That Met QC Criteria
March 31, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000028028
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthritis, Juvenile Idiopathic
-
University of AarhusAarhus University HospitalCompletedPolyarticular Juvenile Rheumatoid Arthritis | Systemic Juvenile Idiopathic Arthritis | Juvenile Idiopathic Arthritis, OligoarthritisDenmark
-
Bangladesh Medical UniversityCompletedJuvenile Idiopathic Arthritis | Polyarticular Juvenile Idiopathic Arthritis | Refractory Polyarticular Juvenile Idiopathic ArthritisBangladesh
-
Assiut UniversityNot yet recruitingJuvenile Idiopathic Arthritis | Tenosynovitis | Polyarticular Juvenile Idiopathic Arthritis | Oligoarticular Juvenile Idiopathic Arthritis
-
Changchun GeneScience Pharmaceutical Co., Ltd.RecruitingActive Systemic Juvenile Idiopathic ArthritisChina
-
Novartis PharmaceuticalsPediatric Rheumatology International Trials OrganizationCompletedSystemic Juvenile Idiopathic Arthritis With Active FlareUnited States, Argentina, Canada, Switzerland, Germany, Israel, South Africa, Belgium, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru
-
Novartis PharmaceuticalsCompletedSystemic Juvenile Idiopathic Arthritis (SJIA)Italy, Russian Federation, Turkey, Belgium, Spain, Germany, France, Israel, Canada, United States, Hungary, Austria, Brazil, Sweden, Netherlands, Poland
-
PfizerRecruitingPolyarticular Juvenile Idiopathic Arthritis | Psoriatic Arthritis, JuvenileSouth Korea
-
NovartisCompletedArthritis, Juvenile RheumatoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaNot yet recruitingSystemic Juvenile Idiopathic Arthritis (sJIA)Italy
-
University of British ColumbiaUniversity of Manitoba; The Hospital for Sick Children; McGill University Health... and other collaboratorsRecruiting
Clinical Trials on Taking Charge: Managing JIA Online
-
The Hospital for Sick ChildrenCompleted
-
The Hospital for Sick ChildrenMcGill University; University of Alberta; McMaster University; Hamilton Health... and other collaboratorsCompleted
-
Medical College of WisconsinUniversity of Illinois at ChicagoRecruiting
-
The Hospital for Sick ChildrenDalhousie University; IWK Health Centre; Provincial Health Services Authority; The... and other collaboratorsCompletedJuvenile Idiopathic ArthritisCanada
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health...Completed
-
University of CalgaryCompletedCoronary Artery Disease | Acute Coronary SyndromeCanada
-
University of NottinghamUniversity of Warwick; Loughborough University; Institute of Mental Health NottinghamCompletedOccupational Stress | Mental Health Wellness 1 | Absence | Sickness Behavior | Occupational NeurosisUnited Kingdom
-
Hôpital NOVORecruiting
-
University College, LondonUnknownInflammatory Bowel Disease (IBD)